doi:10.1006/abbi.2000.2197
Atherosclerosis progression, as a chronic inflammatory mechanism, is characterized by immune system dysregulation associated with increased pro-inflammatory cytokine production, including interleukin 6 (IL-6), tumor necrosis factor- (TNF-), and IL-1, as well as pattern recognition receptor proteins like CRP (170, 261267)
This blockage can especially impact speech and cognitive development
P Dentico, A Volpe, R Buongiorno, I Grattagliano, E Altomare, G Tantimonaco, G Scotto, R Sacco, O Schiraldi - [Glutathione in the treatment of chronic fatty liver diseases] - Recenti Prog Med - Jul-Aug 1995
This capability allows nanocarriers to dynamically adapt their therapeutic profiles in response to physiological changes, which is particularly important for chronic infections or inflammation-prone conditions where disease states evolve rapidly [242]